Invasive Ductal Breast Carcinoma
(UMLS:C1134719)
- Definition:
- An invasive (infiltrating) CARCINOMA of the mammary ductal system (MAMMARY GLANDS) in the human BREAST.
- UMLS ID:
- C1134719
- MeSH ID:
- N/A
Synonym(s)
1.
Invasive Ductal Breast Carcinoma
2.
BREAST CANCER DUCTAL INFILTRATING
3.
Infiltrating Ductal Adenocarcinoma
4.
Infiltrating Ductal Breast Carcinoma
5.
Infiltrating Ductal Carcinoma
6.
Infiltrating Ductal Carcinoma of Breast
7.
Infiltrating Ductal Carcinoma of the Breast
8.
Infiltrating duct carcinoma of breast
9.
Infiltrating ductal carcinoma of breast
10.
Infiltrating ductular carcinoma
11.
Invasive Ductal Adenocarcinoma
12.
Invasive Ductal Carcinoma
13.
Invasive Ductal Carcinoma of Breast
Associated Drug(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Fingolimod Hydrochloride | FAERS: 40 | US FAERS | |
| 2 | Norgestrel | FAERS: 35 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 3 | Dimethyl Fumarate | FAERS: 34 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 4 | Lenalidomide | FAERS: 15 | US FAERS | |
| 5 | Imatinib Mesylate | FAERS: 9 | US FAERS | |
| 6 | Valsartan | FAERS: 7 | US FAERS | |
| 7 | etonogestrel | FAERS: 7 | US FAERS | |
| 8 | Estrogens, Conjugated (USP) | FAERS: 6 | US FAERS | |
| 9 | Testosterone | FAERS: 6 | US FAERS | |
| 10 | Glatiramer Acetate | FAERS: 4 | US FAERS | |
| 11 | Letrozole | FAERS: 4 | US FAERS | |
| 12 | Teriparatide | FAERS: 4 | US FAERS | |
| 13 | Zoledronic Acid | FAERS: 4 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 14 | Anastrozole | FAERS: 3 | US FAERS | |
| 15 | Clomiphene | FAERS: 3 | US FAERS | |
| 16 | Estrogens, Conjugated (USP) | FAERS: 3 | US FAERS | |
| 17 | Liraglutide | FAERS: 3 | US FAERS | |
| 18 | teriflunomide | FAERS: 3 | US FAERS | |
| 19 | tofacitinib | FAERS: 3 | US FAERS | |
| 20 | 17 alpha-Hydroxyprogesterone Caproate | FAERS: 2 | US FAERS | |
| 21 | Aripiprazole | FAERS: 2 | US FAERS | |
| 22 | Colchicine | FAERS: 2 | US FAERS | |
| 23 | Cyclosporine | FAERS: 2 | US FAERS | |
| 24 | Finasteride | FAERS: 2 | US FAERS | |
| 25 | Imatinib Mesylate | FAERS: 2 | US FAERS | |
| 26 | Losartan | FAERS: 2 | US FAERS | |
| 27 | Octreotide | FAERS: 2 | US FAERS | |
| 28 | Paclitaxel | FAERS: 2 | US FAERS | |
| 29 | Sitagliptin Phosphate | FAERS: 2 | US FAERS | |
| 30 | Thyroxine | FAERS: 2 | US FAERS | |
| 31 | norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination | FAERS: 2 | US FAERS | |
| 32 | romidepsin | FAERS: 2 | US FAERS | |
| 33 | 4-hydroxybutyric acid | FAERS: 1 | US FAERS | |
| 34 | Alendronate | FAERS: 1 | US FAERS | |
| 35 | Arthrotec | FAERS: 1 | US FAERS | |
| 36 | Canagliflozin | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 37 | Clozapine | FAERS: 1 | US FAERS | |
| 38 | Doxorubicin | FAERS: 1 | US FAERS | |
| 39 | Epoprostenol | FAERS: 1 | US FAERS | |
| 40 | Estradiol | FAERS: 1 | US FAERS | |
| 41 | Everolimus | FAERS: 1 | US FAERS | |
| 42 | Fulvestrant | FAERS: 1 | US FAERS | |
| 43 | Gefitinib | FAERS: 1 | US FAERS | |
| 44 | NuvaRing | FAERS: 1 | US FAERS | |
| 45 | Pioglitazone | FAERS: 1 | US FAERS | |
| 46 | Pregabalin | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 47 | Raloxifene Hydrochloride | FAERS: 1 | US FAERS | |
| 48 | Ruxolitinib phosphate | FAERS: 1 | US FAERS | |
| 49 | Solifenacin Succinate | FAERS: 1 | US FAERS | |
| 50 | Tamoxifen | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 51 | Thalidomide | FAERS: 1 | US FAERS | |
| 52 | Tolvaptan | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 53 | Vemurafenib | FAERS: 1 | US FAERS | |
| 54 | Verapamil | FAERS: 1 | US FAERS | |
| 55 | ambrisentan | FAERS: 1 | US FAERS | |
| 56 | bosutinib | FAERS: 1 | US FAERS | |
| 57 | bupropion hydrochloride, naltrexone hydrochoride drug combination | FAERS: 1 | US FAERS | |
| 58 | exemestane | FAERS: 1 | US FAERS | |
| 59 | niraparib | FAERS: 1 | US FAERS | |
| 60 | osimertinib | FAERS: 1 | US FAERS | |
| 61 | palbociclib | FAERS: 1 | US FAERS | |
| 62 | Dutasteride | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.